We are live on ! Find out more
CMBA

C.M. Bidwell & Associates Portfolio holdings

AUM $245M
1-Year Est. Return 23.8%
This Fund
S&P 500
This Quarter Est. Return
+13.58%
1 Year Est. Return
+23.8%
3 Year Est. Return
+70.62%
5 Year Est. Return
+83.19%
10 Year Est. Return
+679.91%
AUM
$245M
AUM Growth
+$30.5M
Cap. Flow
+$8.23M
Cap. Flow %
3.36%
Top 10 Hldgs %
44.48%
Holding
554
New
71
Increased
95
Reduced
70
Closed
60

Top Sells

Rank Stock Value
1
VRT icon
Vertiv
VRT
+$587K
2
AKAM icon
Akamai
AKAM
+$424K
3
CHRW icon
C.H. Robinson
CHRW
+$399K
4
TWLO icon
Twilio
TWLO
+$393K
5
VGSH icon
Vanguard Short-Term Treasury ETF
VGSH
+$311K

Sector Composition

Rank Sector Weight
1 Miscellaneous 80.21%
2 Technology 7.58%
3 Communication Services 2.35%
4 Industrials 2.12%
5 Financials 1.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GEN icon
326
Gen Digital
GEN
$18.2B
$5.55K ﹤0.01%
223
RVSB icon
327
Riverview Bancorp
RVSB
$106M
$5.55K ﹤0.01%
+1,022
New +$5.66K
VRSN icon
328
VeriSign
VRSN
$26.4B
$5.53K ﹤0.01%
22
TSLA icon
329
Tesla
TSLA
$1.44T
$5.47K ﹤0.01%
13
DFSD
330
Dimensional Short-Duration Fixed Income ETF
DFSD
$7.25B
$5.4K ﹤0.01%
113
DKNG icon
331
DraftKings
DKNG
$12.2B
$5.36K ﹤0.01%
212
IMAX icon
332
IMAX
IMAX
$2.85B
$5.34K ﹤0.01%
134
MED icon
333
Medifast
MED
$135M
$5.27K ﹤0.01%
+497
New +$5.73K
LDOS icon
334
Leidos
LDOS
$16.2B
$5.25K ﹤0.01%
51
-926
-95% -$123K
LASR icon
335
nLIGHT
LASR
$2.32B
$5.22K ﹤0.01%
+75
New +$5.23K
PTCT icon
336
PTC Therapeutics
PTCT
$5.53B
$5.22K ﹤0.01%
+64
New +$4.62K
AVY icon
337
Avery Dennison
AVY
$12.8B
$5.2K ﹤0.01%
32
SNDA icon
338
Sonida Senior Living
SNDA
$1.89B
$5.18K ﹤0.01%
+127
New +$4.55K
MOV icon
339
Movado Group
MOV
$727M
$5.11K ﹤0.01%
+130
New +$4.06K
JKHY icon
340
Jack Henry & Associates
JKHY
$11.3B
$5.1K ﹤0.01%
37
VRTX icon
341
Vertex Pharmaceuticals
VRTX
$131B
$4.97K ﹤0.01%
10
ARI
342
Apollo Commercial Real Estate
ARI
$857M
$4.9K ﹤0.01%
459
TTC icon
343
Toro Company
TTC
$8.76B
$4.87K ﹤0.01%
50
NWE icon
344
NorthWestern Energy
NWE
$4.26B
$4.87K ﹤0.01%
68
ENTA icon
345
Enanta Pharmaceuticals
ENTA
$378M
$4.83K ﹤0.01%
331
GERN icon
346
Geron
GERN
$867M
$4.71K ﹤0.01%
+3,682
New +$5.19K
ASB icon
347
Associated Banc-Corp
ASB
$5.68B
$4.71K ﹤0.01%
153
AVA icon
348
Avista
AVA
$3.09B
$4.71K ﹤0.01%
115
PECO icon
349
Phillips Edison & Co
PECO
$4.94B
$4.7K ﹤0.01%
113
HNST icon
350
The Honest Company
HNST
$585M
$4.69K ﹤0.01%
+1,281
New +$4.32K

Similar funds

C.M. Bidwell & Associates's Q2 2026 Portfolio in Review

As of Q2 2026, C.M. Bidwell & Associates held 554 positions worth $245M, up 14% from $214M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

C.M. Bidwell & Associates deployed $8.23M of net new capital in Q2 2026, opening 71 new positions and adding to 95 existing holdings. Its largest new stake was Dow Inc: 15,138 shares worth $414K.

By sector, the portfolio is most concentrated in Miscellaneous at 80% of assets, down from 82% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Vertiv, an estimated $587K trimmed.

  • C.M. Bidwell & Associates's largest Q2 2026 buy was Dow Inc: 15,138 shares worth $414K.
  • C.M. Bidwell & Associates added most to Vanguard S&P 500 ETF in Q2 2026, an estimated $1.23M increase.
  • C.M. Bidwell & Associates's biggest Q2 2026 reduction was Vertiv, cutting an estimated $587K.
  • C.M. Bidwell & Associates fully exited C.H. Robinson in Q2 2026, selling an estimated $399K.
  • C.M. Bidwell & Associates's ten largest holdings make up 44% of its $245M portfolio in Q2 2026.
  • C.M. Bidwell & Associates opened 71 new positions and closed 60 in Q2 2026.
  • C.M. Bidwell & Associates's portfolio value rose 14% quarter-over-quarter to $245M.

Based on C.M. Bidwell & Associates's 13F filing for Q2 2026, filed 11 Aug 2026.